Skip to content

Free cash flow yield at other companies

Eli Lilly logo
Eli LillyLLY
1.4%+0.9pp
AbbVie logo
AbbVieABBV
5.2%+1.0pp
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
-5.8%-2.5pp
Establishment Labs logo
Establishment LabsESTA
-2.5%-0.9pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
51.4%-0.2pp

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$317.46M+7.8%
Enterprise value$371.78M+0.1%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

Based on trailing twelve months.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed August 1, 2025, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s free cash flow yield?
AirSculpt Technologies, Inc. (AIRS) reported free cash flow yield of -0.1% in Q2 2025.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.